A major shift came in 2017 when semaglutide was approved for diabetes
doi: 10.3389/fmed.2025.1618275 Received 25 April 2025 Accepted 18 July 2025 Published 14 August 2025 Volume 12 - 2025 Edited by Zhengyang Bao, Wuxi Maternity and Child Health Care Hospital, China Reviewed by Jinwei Zhang, University of Exeter, United Kingdom Ernest Saenz, Heidelberg University, Germany Updates Copyright 2025 Dua, Kumari, Singh, Kumar, Pradeep, Ojesina and Kumar
Side effects and risks Januvia and metformin have different effects on the body, so both medications can cause different side effects
Research-grade peptides vary in purity and potency
Reported research observations include: All findings are derived from controlled clinical research